Cargando…
Integrative genomics reveals pathogenic mediator of valproate-induced neurodevelopmental disability
Prenatal exposure to the anti-seizure medication sodium valproate (VPA) is associated with an increased risk of adverse postnatal neurodevelopmental outcomes, including lowered intellectual ability, autism spectrum disorder and attention-deficit hyperactivity disorder. In this study, we aimed to cla...
Autores principales: | Feleke, Rahel, Jazayeri, Dana, Abouzeid, Maya, Powell, Kim L, Srivastava, Prashant K, O’Brien, Terence J, Jones, Nigel C, Johnson, Michael R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679160/ https://www.ncbi.nlm.nih.gov/pubmed/36071595 http://dx.doi.org/10.1093/brain/awac296 |
Ejemplares similares
-
Anti-Epileptic Drug Combination Efficacy in an In Vitro Seizure Model – Phenytoin and Valproate, Lamotrigine and Valproate
por: Taing, Kim Det, et al.
Publicado: (2017) -
Long-Term Valproate Treatment Increases Brain Neuropeptide Y Expression and Decreases Seizure Expression in a Genetic Rat Model of Absence Epilepsy
por: Elms, Johanna, et al.
Publicado: (2013) -
Altered cortical thickness following prenatal sodium valproate exposure
por: Wood, Amanda G, et al.
Publicado: (2014) -
Sleep in Children With Neurodevelopmental Disabilities During COVID-19: An Integrative Review
por: Kronk, Rebecca, et al.
Publicado: (2023) -
Effectiveness of hemodialysis in a case of severe valproate overdose
por: Nasa, Prashant, et al.
Publicado: (2011)